Pegavision Corporation (TPE:6491)

Market Cap	25.19B -6.5%
Revenue (ttm)	7.33B +9.7%
Net Income	1.61B -11.0%
EPS	20.40 -11.2%
Shares Out	76.80M
PE Ratio	16.08
Forward PE	13.63
Dividend	10.00 (3.08%)
Ex-Dividend Date	Aug 7, 2026

Volume	451,425
Open	331.00
Previous Close	328.00
Day's Range	323.50 - 331.00
52-Week Range	270.50 - 352.50
Beta	0.87
Analysts	Buy
Price Target	354.40 (+9.21%)
Earnings Date	Jul 29, 2026

About Pegavision

Pegavision Corporation manufactures and sells medical devices, and optical and precision instruments in Taiwan. It offers soft contact lenses. The company was founded in 2009 and is based in Taoyuan City, Taiwan. Pegavision Corporation operates as a subsidiary of Pegatron Corporation.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6491

Financial Performance

In 2025, Pegavision's revenue was 7.04 billion, an increase of 3.26% compared to the previous year's 6.82 billion. Earnings were 1.63 billion, a decrease of -11.07%.

Analyst Summary

According to 5 analysts, the average rating for 6491 stock is "Buy." The 12-month stock price target is $354.40, which is an increase of 9.21% from the latest price.

Price Target

$354.40

(9.21% upside)

Analyst Consensus: Buy